Serial Monitoring of Circulating Tumor DNA in Patients With Metastatic Colorectal Cancer to Predict the Therapeutic Response

RAS mutation analysis in circulating tumor DNA from patients with metastatic colorectal cancer: the AGEO RASANC prospective multicenter study

(2018) J B Bachet et al.   ANNALS OF ONCOLOGY

Monitoring the effect of first line treatment in RAS/RAF mutated metastatic colorectal cancer by serial analysis of tumor specific DNA in plasma

(2018) C. B. Thomsen et al.   JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH

Early circulating tumor DNA dynamics and clonal selection with palbociclib and fulvestrant for breast cancer

(2018) Ben O’Leary et al.   Nature Communications

Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

(2018) Freddie Bray et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Genomic Landscape of Cell-Free DNA in Patients with Colorectal Cancer

(2017) John H. Strickler et al.   Cancer Discovery

Circulating Cell-Free DNA to Guide Prostate Cancer Treatment with PARP Inhibition

(2017) Jane Goodall et al.   Cancer Discovery

Molecular profiling of metastatic colorectal tumors using next-generation sequencing: a single-institution experience

(2017) Jun Gong et al.   Oncotarget

Individualised multiplexed circulating tumour DNA assays for monitoring of tumour presence in patients after colorectal cancer surgery

(2017) Sarah B. Ng et al.   Scientific Reports

Challenging chemoresistant metastatic colorectal cancer: therapeutic strategies from the clinic and from the laboratory

(2016) A. Sartore-Bianchi et al.   ANNALS OF ONCOLOGY

ESMO consensus guidelines for the management of patients with metastatic colorectal cancer

(2016) E. Van Cutsem et al.   ANNALS OF ONCOLOGY

Dual-targeted therapy with trastuzumab and lapatinib in treatment-refractory, KRAS codon 12/13 wild-type, HER2-positive metastatic colorectal cancer (HERACLES): a proof-of-concept, multicentre, open-label, phase 2 trial

(2016) Andrea Sartore-Bianchi et al.   LANCET ONCOLOGY

Circulating tumor DNA detection in lung cancer patients before and after surgery

(2016) Nannan Guo et al.   Scientific Reports

Application of Circulating Tumor DNA as a Non-Invasive Tool for Monitoring the Progression of Colorectal Cancer

(2016) Jiaolin Zhou et al.   PLoS One

Characterizing the patterns of clonal selection in circulating tumor DNA from patients with colorectal cancer refractory to anti-EGFR treatment

(2015) M. P. Morelli et al.   ANNALS OF ONCOLOGY

Circulating tumor DNA as an early marker of therapeutic response in patients with metastatic colorectal cancer

(2015) J. Tie et al.   ANNALS OF ONCOLOGY

Analysis of circulating tumour DNA to monitor disease burden following colorectal cancer surgery

(2015) Thomas Reinert et al.   GUT

Metastatic Colorectal Cancer: Current State and Future Directions

(2015) Marwan G. Fakih   JOURNAL OF CLINICAL ONCOLOGY

Clonal evolution and resistance to EGFR blockade in the blood of colorectal cancer patients

(2015) Giulia Siravegna et al.   NATURE MEDICINE

PD-1 Blockade in Tumors with Mismatch-Repair Deficiency

(2015) Dung T. Le et al.   NEW ENGLAND JOURNAL OF MEDICINE

Early tumor cavitation with regorafenib in metastatic colorectal cancer: A case report

(2015) KENTA KAWASAKI et al.   Oncology Letters

HER2 genomic amplification in circulating tumor DNA from patients with cetuximab-resistant colorectal cancer

(2015) Naoki Takegawa et al.   Oncotarget

Mutation profiling of tumor DNA from plasma and tumor tissue of colorectal cancer patients with a novel, high-sensitivity multiplexed mutation detection platform

(2015) Evelyn Kidess et al.   Oncotarget

Liquid Biopsies: Genotyping Circulating Tumor DNA

(2014) Luis A. Diaz et al.   JOURNAL OF CLINICAL ONCOLOGY

Clinical validation of the detection of KRAS and BRAF mutations from circulating tumor DNA

(2014) Alain R Thierry et al.   NATURE MEDICINE

Detection of Circulating Tumor DNA in Early- and Late-Stage Human Malignancies

(2014) C. Bettegowda et al.   Science Translational Medicine

Transient therapy-related surge in serum tumor biomarkers: Characterizing behavior and postulating its biologic role

(2012) Suneel D. Mundle et al.   CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY

Molecular diagnostics and personalized medicine in oncology: Challenges and opportunities

(2012) Nicola Normanno et al.   JOURNAL OF CELLULAR BIOCHEMISTRY

Comprehensive molecular characterization of human colon and rectal cancer

(2012)   NATURE

Association of Computed Tomography Morphologic Criteria With Pathologic Response and Survival in Patients Treated With Bevacizumab for Colorectal Liver Metastases

(2009) Yun Shin Chun   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Circulating mutant DNA to assess tumor dynamics

(2008) Frank Diehl et al.   NATURE MEDICINE